For overall survival, 311 nominally significant gene combinations (10 two‐gene combinations, 301 three‐gene combinations); for PSA progression, there were 566 nominally significant gene combinations (16 two‐gene combinations, 550 three‐gene combinations); and for radioclinical survival, there were 160 nominally significant combinations (6 two‐gene combinations, 154 three‐gene combinations).
← all excerpts
Detection of CTC Clusters and a Dedifferentiated RNA-Expression Survival Signature in Prostate Cancer.
1
—
—